Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

NCT01775930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: Carfilzomib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]